The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|24|34|3698-3710

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.34, 2017-11, pp. : 3698-3710

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Epigenetic Modifiers in Cancer

By  

Current Medicinal Chemistry, Vol. 14, Iss. 24, 2007-10 ,pp. : 2540-2547

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Topical Immune Response Modifiers in Skin Cancer

By Woodmansee Courtney   Pillow Jessica   Skinner Robert B.  

Drugs, Vol. 66, Iss. 13, 2006-01 ,pp. : 1657-1664

Adis International

Access to resources Recommend Favorite

Metabolic Changes in Cancer Patients

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 10, Iss. 4, 2011-08 ,pp. : 281-285

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Alterations in Renal and Prostate Cancer

By  

Current Drug Metabolism, Vol. 17, Iss. 2, 2016-02 ,pp. : 150-155

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroendocrinology of insulin resistance: metabolic and endocrine aspects of adiposity

By van Dijk G.   de Vries K.   Benthem L.   Nyakas C.   Buwalda B.   Scheurink A.J.W.  

European Journal of Pharmacology, Vol. 480, Iss. 1, 2003-11 ,pp. : 31-42

Elsevier

Access to resources Recommend Favorite